#227 Baffled by NAFLD?

Swim through the sea of acronyms as Dr Scott Matherly (@liverprof) helps us become a little less baffled by the thought of NAFLD. We discuss the initial diagnosis of fatty liver disease, indications for additional evaluation with imaging and/or biopsy, and potential treatment options. With a quarter of the world affected, it’s crucial to understand the various forms of disease and how to counsel patients about this all-too-common condition!

Show Notes | Subscribe | Spotify | Swag! | Top Picks | Mailing List | [email protected] | Free CME!

Credits

• Written and Produced by: Elena Gibson MD
  



• Infographic and Cover Art: Elena Gibson MD
  



• Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP
  



• Editor: Emi Okamoto MD (written materials); Clair Morgan of nodderly.com
  

  
  



• Guest: Scott Matherly MD
  

Sponsor: Pediatrics On Call

Sponsor:  VCU Health Continuing Education to offer continuing education credits for physicians and other healthcare professionals. Check out curbsiders.vcuhealth.org and create your FREE account!

Time Stamps

• 
  00:00 Intro
  



• 
  03:15 Guest one-liner; Picks of the Week*
:
  

  
  



• 
  08:15 Sponsor


• 
  08:50 Case from Kashlak part 1; What is hepatic steatosis?
  



• 
  11:43 NAFLD acronyms and definitions
  



• 
  18:20 Alcohol and Fatty Liver
  



• 
  23:15 Initial Evaluation of NAFLD
  



• 
  35:12 Dr Matherly’s piel to patients with fatty
  



• 
  41:11 NASH/Fibrosis Risk Assessment
  



• 
  48:54 Outcomes in NASH with Fibrosis
  



• 
  51:20 Statins are safe in liver disease
  



• 
  56:15 Treatment Options (surgery, Vitamin E, Pioglitazone, SLGT2 inhibitors and GLP1 agonists; Coffee?!)


• 
  71:42 Take home points and Outro